中国缺血性卒中及短暂性脑缺血发作患者血脂长期管理科学声明 Scientific Statement on the Long-Term Lipid Management in Patients with Ischemic Stroke and Transient Ischemic Attack in China

Abstract

中国缺血性卒中（ischemic stroke，IS）及TIA疾病负担沉重。LDL-C水平升高是卒中复发的独立危险因素，积极评估患者LDL-C不达标的原因，制订进一步治疗策略、监测频率以提高达标率具有重要临床意义。为加强医务工作者对IS及TIA疾病长期管理及监测的认识，规范长期血脂管理临床实践，中国卒中学会医疗质量管理与促进分会组织相关脑血管病临床医学专家，基于循证证据和临床实践、经多轮专家意见收集和研讨，拟定本科学声明。本科学声明对IS及TIA患者长期血脂管理、长期血脂监测及重点患者血脂管理等方面进行了阐述，以期为提升IS及TIA患者的长期血脂管理临床规范提供参考。 Abstract: The disease burden is substantial among Chinese patients with ischemic stroke (IS) and TIA. High LDL-C level is an independent risk factor for stroke recurrence. It is of clinical significance to assess the reasons resulting in unfavorable LDL-C control in patients, develop further treatment strategies, monitor frequencies to improve the LDL-C target attainment rate. To strengthen the understanding of medical workers on the long-term management and monitoring of IS and TIA, and standardize clinical practice of long-term lipid management, this scientific statement was formulated by clinical experts in cerebrovascular disease organized by the Chinese Stroke Association’s Subcommittee on Medical Quality Management and Promotion. The scientific statement, based on evidence-based research, clinical practice, multiple rounds of expert opinion collection, and thorough discussions, elaborated on long-term lipid management, monitoring, and lipid management in high-risk patients in IS and TIA. It aims to provide reference for improving clinical in long-term lipid management for IS and TIA patients.

Keywords

• 缺血性卒中
• 短暂性脑缺血发作
• 低密度脂蛋白胆固醇
• 血脂管理
• 科学声明
• ischemic stroke
• transient ischemic attack
• low density lipoprotein cholesterol
• lipid management
• scientific statement